Geoff is responsible for driving overall Life Science market strategy across Consigli’s footprint—including Boston/Cambridge, NYC region, & the Mid Atlantic. In his time with Consigli, they have developed an expertise delivering all aspects of Life Science construction for owners and end-users, including fit-out, renovation, expansion, and new construction of both R&D to cGMP/Manufacturing facilities. Geoff works closely with all levels of Consigli’s Life Science team to manage the entire process, including client relations, business development operations, marketing and recruiting. He loves working and collaborating with the many layers of the Life Science market and AEC industry. Geoff received his MBA from Boston College - Carroll School of Management and BA from Tufts University.

Adrian is responsible for leading a dedicated team through the firm's Life Science projects

Applies his architectural and scientific expertise towards lab planning and design, outreach, and thought leadership within the firm

Provides a balanced and holistic vision for each initiative, particularly paying attention to long-term goals for both the team and the client

Focuses on making client labs more sustainable

Institutional Flexibility

One of Adrian's core responsibilities is not just supporting the research behind each lab, but also the flexibility of those institutions. Though the needs of the science are extremely important, losing sight of the big picture can be harmful to the project’s precision and accuracy. Experts must strike a balance with the space provided to measure short-term deliverables alongside the overall strategic plan, and to meet each objective for both the client and SMMA’s practice.

National Science and Technology Practice Leader Frank Angelini has established himself as an industry expert in laboratory design and project management. Whether developing a space where life-saving vaccines will be discovered or designing a university lab to inspire the next generation of researchers, Frank’s expertise guides project teams to innovative solutions. His ability to collaborate with clients to clearly understand their unique needs and translate those needs into building system design can be seen in his successful projects completed worldwide. Frank’s passion for creating spaces that facilitate important research and vaccine developments influences each of his projects.

Paul Bauer, Practice Area Leader, Real Estate, Finance, and Corporate, is a lawyer representing businesses, individuals and institutions throughout Massachusetts in sophisticated transactions with an emphasis on big real estate projects and challenging commercial law issues. Paul regularly advises developers, mortgage lenders, tenants and property owners across various industry sectors in complex development, acquisition, financing, business planning and leasing transactions – both public and private – including the biggest lease in the history of Boston at the time.

Much of Paul’s real estate experience falls into three areas:

Life science and medical school leasing for landlords and tenants. This includes comprehensive, campus-wide representations, as well as one-off projects.

Higher education real estate development, often for major, iconic institutions. According to Paul, “I’ve also served as counsel to the Massachusetts School Building Authority.”

Privately-held real estate projects, representing developers and owners, often family-owned. “I enjoy working with anyone who has or wants a large building,” Paul says.

Developers, investors and property end-users turn to Paul to plan, negotiate and structure real estate-based projects. He advises clients on multi-party, mixed-use and affordable housing projects. As Paul notes, “I also help a number of real estate companies in a variety of commercial sectors – including office, industrial and retail – in the sale, acquisition, financing, management and leasing of their real property investments.” In addition, he adds, “I also advise income property owners on related issues, including real property acquisitions and sales, property ownership structuring and estate planning for developer clients who hold complicated real estate assets.”

While Paul represents property end-users in most commercial segments, he has significant experience representing entrepreneurs and life science companies of all sizes with respect to their property leasing needs. Paul’s experience includes representing a life science company in one of the largest lease transactions ever to occur in the city of Boston. In addition, Paul represents a number of craft brewers and their brewery facilities. This representation includes leasing, financing and permitting services.

In addition, Paul represents privately-held companies for their structural, financing, and contractual needs. He often works with early-stage companies to provide them the counsel necessary to protect their interests in obtaining contracts, investors and lending facilities. Paul is also a co-editor of the Commercial Real Estate Insight & News blog.

In the community, Paul is Chair of the Advisory Board for the Entrepreneurial Innovation Center at Framingham State University, where he advises the Center on its program helping entrepreneurs develop their ideas and small businesses.

Project Executive Alex Main joined Wise Construction in 2009, and has grown to become the area’s industry leader on complex, logistically-challenging projects ranging from $10M - $100M. With a focus on life-science, clinical, and manufacturing facilities, he thoroughly understands the intricacies of these specialized buildings. Alex has worked to bring the latest technologies and delivery methods to every project, including design assist, immersive 3D scanning, virtual pull planning, and cloud-based project management, reducing both project risk and timelines for all his clients. His innate creativity helps him work to develop solutions for complex constructability issues, something that often comes up while converting some of Boston’s oldest buildings into modern lab spaces. A sampling of his clients includes Vertex, Novartis, Takeda, Moderna, Agios, Biogen, Alexandria Real Estate Equities, Jamestown, and Flagship Pioneering. A natural leader, Alex frequently works to mentor some of the industry’s up-and-coming young professionals. He is a graduate of Wentworth Institute of Technology, and is an active member of the WIT Alumni Association, the Spondylitis Association of America, MassBio, and NAIOP

As SGA’s Director of Science and Technology Planning, Matthew leads the programming, planning, and design of research and development facilities for the biomedical, pharmaceutical, academic, and corporate sectors. His specialty is working directly with scientists to create environments which support the physical and process requirements of their work; he especially welcomes opportunities to create unique, specialty labs for novel research. Matthews designs come from a physics-based understanding of scientific and sustainable requirements and an emphasis on the human experience. Named to Fast Company’s list of the World’s Most Innovative Companies in 2018 and 2021, SGA leads the nation in delivering Life Sciences facilities that respond to emerging science trends, while also facilitating and creating opportunities for leading-edge discovery methods.

Senior investment professional on Oxford’s U.S. Investment Team, currently based in New York, responsible for the execution of Oxford’s real estate investment activity across several asset classes and debt and equity strategies. Of note, Sam is currently responsible for the origination and execution of Oxford’s life science platform, with a focus on the east coast markets. Prior to his current role in New York, Sam worked in the Boston, MA office of Oxford, helping to facilitate the growth of a 4.5 million square foot operating platform through acquisitions and development projects, beginning with a $2.5B portfolio acquisition from Equity Office Properties in 2015. In his career, Sam has completed over $5.0B of transactions across North America. Sam received his Bachelor of Commerce from McGill University and is a designated CFA charterholder.

As CEO and President, Kendalle leads the strategic direction for the organization and drives policy advocacy for the industry to ensure that Massachusetts life sciences companies have the best environment possible to research, develop, manufacture, and commercialize breakthrough therapies and cures for people around the world.

Pursuing innovation and delivering for members are the hallmarks of Kendalle’s more than 15 years at MassBio, including the launch of several multi-year initiatives focused on realizing a diverse and equitable life sciences industry, supporting the continued growth and sustainability of the industry throughout Massachusetts, and providing resources and solutions to companies across the industry value chain.

Kendalle has played a critical role in MassBio’s growth into the largest life sciences trade association in the world with over 1,600 members. Kendalle has overseen the rebrand of a number of MassBio’s core programs and services, including the MassBioEdge, MassBio’s savings program which offers members access to industry-leading providers and best in class benefit plans, and MassBio’s highly-rated Employee Rewards program. She also led the development of the MassBioHub conference and business center.

In 2022, Kendalle was instrumental in the launch of MassBio’s newest entrepreneurial accelerator program, MassBioDrive and MassBio’s Innovation Week, two initiatives focused on advancing breakthrough science and providing opportunities for innovators from diverse backgrounds in all areas of the life sciences ecosystem. In 2023, she has been the driving force behind MassBio’s launch of Bioversity, a non-profit created to develop new training pathways and create employer connections for underrepresented populations and individuals traditionally left out of the life sciences, starting with a workforce training center in Dorchester featuring industry-aligned certification and upskilling programs. This year, she also originated a collaboration with McKinsey & Co. to host an annual partnering conference, the Align Summit, for early-stage investors, startups, and strategic partners.

Kendalle has earned wide acclaim for her leadership and is active in mentoring and professional organizations. She is ranked number 33 on Boston Magazine’s list of The 150 Most Influential Bostonians in 2023, a 2022 recipient of the Cambridge Chamber of Commerce Inspire Award recognizing outstanding women leaders in the Cambridge community, a 2022 Boston power player as named by Axios, a 2021 executive fellow in the inaugural class of the Civic Action Project Collaborative, and a 2019 Boston Business Journal 40 under 40 honoree which acknowledges a leader’s impact on Massachusetts’ industries. Currently, Kendalle serves as a Director on the Board of The Boston Foundation, Vice Chair of the Eastern New England Board of Directors for the American Cancer Society, a Director on the Board of the Massachusetts Biotechnology Education Foundation (MassBioEd), and an Advisory Committee member for the Suffolk University Law School All Rise Program.

Prior to joining MassBio, Kendalle practiced law in the areas of Estate and Medicaid Planning, Probate and Asset Protection. She graduated cum laude from Sacred Heart University with a B.A. in Economics and Political Science and received her Juris Doctor from Suffolk University Law School. She resides in Haverhill, Massachusetts with her husband and two children.

As Managing Principal of Griffith Properties, Marci oversees all of the firm’s activities including fundraising, investments and executing the strategies for Griffith Properties Funds. She brings 32 years of experience in principal investing, disposition, valuation and brokerage involving over 525 transactions representing $26 billion of assets. Since 2010, Marci has been operating Griffith Properties as a Women-owned enterprise.

From 1993 to 2009 Marci was an investment sales broker, most recently with Cushman & Wakefield and formerly with Fallon Hines & O’Connor/Trammell Crow Company. In the course of her 18-year Brokerage career Marci closed over 500 investment sales transactions totaling in excess of $25.0 billion and was named by Real Estate Forum as one of the country’s “Superstar” investment sales brokers in three consecutive years. While a Principal at TCC, Marci was ranked among the Top 3 Producers nationwide from 1998 through 2000. She was member of the team recognized by the GBREB’s Commercial Leasing and Investment Committee for closing “The Investment Sales Deal of the Year” multiple times: 1994 (for the $64.6 million Latham Farms Power Center sale in Albany, NY); 1995 (for the $163 million sale of Bay Colony Corporate Center in Waltham, MA); 1996 (for the $91 million Druker 1031 Exchange in Boston); 1999 (for the $403 million MGI New England Portfolios) and 2006 (for the $600 million Technology Square transaction).

Community Service and Professional Affiliations include: Member, Urban Land Institute (ULI); Member and Past President, Real Estate Finance Association (REFA); Member and Past President, NAIOP of MA; Committee Member, Champions for Children’s, Children’s Hospital Boston; Member, Real Estate Committee for Archdiocese of Boston; Board of Trustees, Noble and Greenough School.

In 2000, Marci—along with her father and sister—received the Robert Swain Award for her contribution and achievements in the real estate industry.

Marci is a 1989 graduate of Middlebury College with a Bachelor of Arts in Economics, and a minor in Mathematics. She lives in Weston with her husband, Franz, and her three children.

As Chief Investment Officer at King Street, Mr. Albro has a broad range of responsibilities including acquisitions, dispositions, development, and asset management. Prior to King Street, Mr. Albro most recently served as a Senior Vice President at Beacon Capital Partners, with responsibility for acquisitions and dispositions as well as asset management of the Boston region.

Mr. Robbins is a Senior Vice President whose experience covers the project management and mechanical engineering for college and universities, laboratories and cleanrooms as well modeling systems for true informed design. He has 30 years’ experience in the design of biotech facilities, BSL-2 and BSL-3 laboratories, animal facilities, and academic health and science facilities. He is responsible for the design of projects from conception, including preparation and coordination of working drawings and specifications. Scott embraces the development of mechanical systems concepts, such as the use of high performance HVAC and energy recovery systems, technical oversight, and guidance of project engineering and design. He has extensive knowledge of sustainable building design and construction practices and encourages implementation where appropriate. He is an accredited professional in the United States Green Building Council’s Leadership in Energy and Environmental Design (LEED) Green Building Rating System.

Matt oversees Bulfinch’s Asset Management Team, working closely with Financial Reporting and Acquisitions to ensure the success of the firm’s portfolio management and growth.

Peter Schubert, FAIA is a Design Partner at Ennead Architects. Peter has spent over thirty-years designing award-winning office, commercial life science, vertical laboratories, R&D and innovation centers, academic science, mixed-use residential, hospital and hotel projects in the US and around the world. Fusing a passion for urbanism with iconic architecture that integrates local culture, history and context, he creates purposeful buildings and civic spaces. His work includes: Center East: The New York Blood Center, on the Upper East Side; The Cove Jersey City, a 3,000,000 SF commercial science-led mixed-use development; DIVCO West’s Parcel U project at Cambridge Crossing in MA; and the Alexandria Center for Life Science at East River Science Plaza, the first ground-up commercial lab project in New York City. Ennead has close to 5,000,000 sf of ground-up commercial lab projects across the Northeast. The firm is responsible for projects in the New York area as diverse as The Standard Hotel Highline, the new Koch Research Center at MSK and The Rose Planetarium.

Mike Walsh is a generous and communicative leader with over 26 years’ experience in the construction industry. He has an innate ability to cultivate strong relationships within his project teams and among his clients and business partners. As champion of BOND’s Healthcare & Life Sciences sector, Mike oversees the strategic operations and business development of the Group with a keen eye for efficiency, effectiveness and client satisfaction.

Mike has achieved remarkable results with key players in Boston’s healthcare and life sciences market. He has completed work at major institutions such as Boston Medical Center, Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Mass. Eye and Ear and Steward Healthcare (formerly Caritas).

An architectural engineering graduate of Wentworth Institute of Technology and LEED accredited professional, Mike’s industry experience has earned him the leadership position of Supporting Member Liaison on the Board of Directors for the (NEHES) New England Healthcare Engineers Society.